Oncostatin M promotes bone formation independently of resorption when signaling through leukemia inhibitory factor receptor in mice
Emma C. Walker(Washington University in St. Louis), Natalie A. Sims(The University of Melbourne), Ingrid J. Poulton(St Vincents Institute of Medical Research), Matthew T. Gillespie(Hudson Institute of Medical Research), Tania J. Fernandes(Barwon Health), Nicos A. Nicola(The University of Melbourne), Matthew J. Constable(Barwon Health), Jian‐Guo Zhang(Nantong University), Melissa Solano(The Ohio State University), T. John Martin(St Vincent's Hospital Melbourne), Narelle E. McGregor(St. Vincent's Medical Center), Sueli Pompolo(St Vincents Institute of Medical Research), Geoffrey C. Nicholson(University of Salford)
Cited by 303
Related Papers
Modulation of Osteoclast Differentiation and Function by the New Members of the Tumor Necrosis Factor Receptor and Ligand Families
|Endocrine Reviews|1999|2.3k
A family of cytokine-inducible inhibitors of signalling
|Nature|1997|2.1k
IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis
|Journal of Clinical Investigation|1999|1.7k
Tumor Necrosis Factor α Stimulates Osteoclast Differentiation by a Mechanism Independent of the Odf/Rankl–Rank Interaction
|The Journal of Experimental Medicine|2000|1.3k
Expression cloning of a receptor for human granulocyte‐macrophage colony‐stimulating factor.
|The EMBO Journal|1989|699